Skip to main content
Premium Trial:

Request an Annual Quote

Tripos, Continuing Reorganization, Sells Four UK Buildings

NEW YORK (GenomeWeb News) — Tripos has sold four buildings at its Bude, UK, Discovery Research location to real estate investors and Park Research, a local chemistry company, according to a Securities and Exchange Commission filing last week.
The move, part of Tripos’ plan to sell its chemical research units, enabled the company to recognize around $1.3 million in gross proceeds.
On Nov. 14 Tripos said it was “engaged in advanced discussions” for the sale of the entire Discovery Research division, of which the UK facilities were a part.
The company is currently trying to become a privately held entity that will focus exclusively on developing and marketing its software and informatics business, which was bought by Vector Capital on Nov. 20 for $26.5 million in cash.
As part of Vector, the informatics business will continue to operate under the Tripos name, will remain in St. Louis, and will retain much of the same informatics and software research staff.

Filed under

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.